XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2022   18,730,380    
Beginning balance at Dec. 31, 2022 $ 562,147 $ 226,592 $ 435,085 $ (99,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (26,384)   (26,384)  
Share-based compensation expense 1,984 $ 1,984    
Common stock issued - Stock grants (in shares)   59,311    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (1,239)     (1,239)
Dividends declared on common stock (8,569)   (8,569)  
Common stock repurchased (in shares)   (13,094)    
Common stock repurchased (316) $ (316) 0  
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2023   18,776,597    
Ending balance at Jun. 30, 2023 527,623 $ 228,260 400,132 (100,769)
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2023   18,767,811    
Beginning balance at Mar. 31, 2023 574,994 $ 227,293 433,459 (85,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (31,442)   (31,442)  
Share-based compensation expense 968 $ 968    
Common stock issued - Stock grants (in shares)   8,885    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (15,011)     (15,011)
Dividends declared on common stock (1,885)   (1,885)  
Common stock repurchased (in shares)   (99)    
Common stock repurchased (1) $ (1)    
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2023   18,776,597    
Ending balance at Jun. 30, 2023 $ 527,623 $ 228,260 400,132 (100,769)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2023 18,810,055 18,810,055    
Beginning balance at Dec. 31, 2023 $ 538,387 $ 229,889 395,357 (86,859)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (13,735)   (13,735)  
Share-based compensation expense 1,966 $ 1,966    
Common stock issued - Stock grants (in shares)   60,483    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) (6,367)     (6,367)
Common stock repurchased (in shares)   (12,973)    
Common stock repurchased $ (134) $ (134)    
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2024 18,857,565 18,857,565    
Ending balance at Jun. 30, 2024 $ 520,117 $ 231,721 381,622 (93,226)
Common stock shares outstanding, beginning balance (in shares) at Mar. 31, 2024   18,857,565    
Beginning balance at Mar. 31, 2024 527,333 $ 230,814 387,860 (91,341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (6,238)   (6,238)  
Share-based compensation expense 907 $ 907    
Common stock issued - Stock grants 0      
Other comprehensive income (loss) $ (1,885)     (1,885)
Common stock shares outstanding, ending balance (in shares) at Jun. 30, 2024 18,857,565 18,857,565    
Ending balance at Jun. 30, 2024 $ 520,117 $ 231,721 $ 381,622 $ (93,226)